HemoCath™ is a breakthrough medical device that will transform heart failure (HF) management. It is uniquely designed to be an easy-to-use pulmonary artery catheter (PAC) for DIRECT MONITORING of pulmonary artery (PA) pressure and central venous pressure (CVP), therefore providing PRECISE and IMMEDIATE metrics of fluid status in HF patients.
HemoCath will allow clinicians to monitor over several hours/days the two most important measures of fluid status in HF patients — PA pressure and CVP.